5-phosphoribosyl-1-amine (PRA) is the first committed intermediate in de novo purine biosynthesis. In Biological Chemistry II, it forms when PRPP is converted by amidophosphoribosyltransferase.
5-phosphoribosyl-1-amine (PRA) is the first committed intermediate in de novo purine biosynthesis in Biological Chemistry II. Once the cell makes PRA, it has moved past a general activated sugar phosphate and into the pathway that will build purine nucleotides from scratch.
PRA forms when PRPP reacts with an amino group donated by glutamine, and the enzyme that catalyzes this step is amidophosphoribosyltransferase, also called glutamine phosphoribosyl amidotransferase. That enzyme swaps the pyrophosphate on PRPP for an amine, creating the ribose-phosphate scaffold that the purine ring will be built onto.
This step matters because it is committed. PRPP can still be used for several other nucleotide-related pathways before this point, but once PRA is made, the cell is on the purine route. That is why this reaction is often treated as a control point for purine synthesis, not just another intermediate on a list.
From there, PRA is quickly converted through several more intermediates, including glycinamide ribonucleotide (GAR) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), before the pathway reaches inosine monophosphate (IMP). IMP is the branch point precursor that can be turned into AMP or GMP, so PRA sits near the beginning of the road to the cell’s main purine nucleotides.
A useful way to picture PRA is as the handoff point between activated ribose chemistry and ring construction. PRPP is the activated starting material, PRA is the first nitrogen-containing intermediate, and the rest of the pathway keeps adding atoms until the purine ring is complete. If a problem asks you to identify the committed step, the enzyme, or the first amine-containing intermediate, PRA is the answer you are looking for.
PRA also ties into regulation. Cells do not want to spend energy making purines when nucleotide levels are already high, so the early steps of de novo synthesis are tightly controlled. When you see PRA in a pathway question, think about flow control, commitment, and whether the cell is making purines de novo instead of salvaging them.
PRA shows up whenever a Biochemical Chemistry II question is asking where purine synthesis really starts to become specific. Before PRA, PRPP is still a flexible activated sugar that can feed other pathways. After PRA, the pathway is committed to making purines, so this step helps explain how cells regulate nucleotide production without wasting resources.
It also connects the chemistry to the pathway logic. You are not just memorizing a name, you are tracking how glutamine donates nitrogen, how PRPP is converted into a more specialized intermediate, and how the pathway moves toward IMP, AMP, and GMP. That makes PRA a useful checkpoint when you are tracing carbon and nitrogen flow through metabolism.
In problem sets and pathway maps, PRA is often the first place where the de novo purine route becomes easy to distinguish from salvage. If a question asks why a mutation, inhibitor, or metabolic imbalance changes purine output, the answer often comes back to this early committed step or the enzyme that makes PRA.
Keep studying Biological Chemistry II Unit 5
Visual cheatsheet
view galleryPRPP
PRPP is the activated ribose donor that comes before PRA. It already has the phosphate-rich structure needed to start nucleotide synthesis, but it is not yet committed to purines. When you trace the pathway, PRPP is the substrate and PRA is the first nitrogen-containing product that locks the cell into de novo purine synthesis.
Amidophosphoribosyltransferase
This is the enzyme that catalyzes the PRPP to PRA conversion. In pathway questions, it is the name attached to the committed step, so it is often the best clue that the problem is testing regulation of purine biosynthesis. If the enzyme is blocked, PRA formation drops and the whole de novo pathway slows down.
5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)
AICAR is much later in the same purine biosynthesis pathway, so it helps show how far PRA has to travel before a purine ring is completed. PRA is an early precursor, while AICAR appears after several ring-building steps. Comparing them is a good way to map the order of intermediates.
Purine Nucleotide
PRA is upstream of the nucleotides your cells actually use, like ATP and GTP. It does not function as an energy currency itself, but it is part of the synthesis pathway that supplies the precursors for those molecules. Seeing PRA in context helps you connect metabolism to DNA, RNA, and energy chemistry.
A quiz item might give you a purine pathway diagram and ask you to identify the first committed intermediate, or to match the enzyme with the product it makes. If PRA appears in a short-answer question, the safest move is to place it right after PRPP and before GAR in de novo purine synthesis.
You may also be asked to explain what happens if amidophosphoribosyltransferase is inhibited. In that case, say that PRA formation falls, which slows the committed step and reduces downstream purine nucleotide production. For pathway tracing questions, use PRA as a checkpoint that separates general PRPP metabolism from the specific purine-building sequence.
If the prompt is asking why cells regulate this step, connect PRA to metabolic demand. High nucleotide demand pushes flux through the pathway, while excess purines usually feeds back to slow early synthesis. That kind of answer shows you can move from the molecule to the regulation pattern.
PRPP and PRA are easy to mix up because PRA is made directly from PRPP, but they are not the same thing. PRPP is the activated sugar precursor, while PRA is the first committed product in purine biosynthesis. If a question asks for the substrate, start with PRPP; if it asks for the committed intermediate, pick PRA.
5-phosphoribosyl-1-amine (PRA) is the first committed intermediate in de novo purine biosynthesis.
PRA is formed from PRPP by amidophosphoribosyltransferase, also called glutamine phosphoribosyl amidotransferase.
Once PRA is made, the cell is committed to making purines rather than using PRPP for other pathways.
PRA sits upstream of GAR, AICAR, and IMP, so it marks the early part of the pathway that leads to AMP and GMP.
If you are tracing regulation, think of PRA as a checkpoint for whether the cell is making purines de novo.
PRA is the first committed intermediate in de novo purine synthesis. It is made when PRPP is converted by amidophosphoribosyltransferase, and it marks the point where the pathway is definitely headed toward purine nucleotide production.
No. PRPP is the activated sugar phosphate that comes before PRA, while PRA is the product formed after an amine is added. That difference matters because PRPP can still feed multiple pathways, but PRA means the cell has entered the committed purine route.
Amidophosphoribosyltransferase makes PRA from PRPP. You may also see the enzyme called glutamine phosphoribosyl amidotransferase. If a question asks for the regulated first step of purine biosynthesis, this enzyme is the one to name.
Because once PRA forms, the pathway is locked into de novo purine production. Before that point, PRPP is still available for other reactions, but after PRA the cell is committed to building the purine ring and eventually making IMP, AMP, and GMP.